Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Blood-borne specialty page provides blood-borne-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Novel Ebola Vaccine Provides Sustained Antibody Response One Year After Administration
The results of a recent Phase IB study show that the novel Ebola vaccine, V920, was well-tolerated and “stimulated a rapid onset of binding and neutralizing antibodies,” which persisted for up to 1 year.
Researchers Make Interesting Discovery Regarding the Half-Life of RCs in HCV
Researchers from the UNC Lineberger Comprehensive Cancer Center elucidate the mode of action of #NS5A inhibitors, and learn more about the half-life of RCs in hepatitis C viruses.
Top 5 <i>Contagion</i>® News Articles for the Week of June 11, 2017
New drugs for HIV, the growing rate of antibiotic resistance, a new hepatitis C treatment option, and updates on the Ebola outbreak and Lyme disease diagnostics, make up the Top 5 articles for this week.
New Hepatitis C Treatment Option Available for Patients Who Failed DAA Therapy
Findings from a clinical trial from researchers at Hospital Saint Joseph in Marseilles give new hope to patients with HCV in whom treatment with direct-acting antivirals previously failed.
ASM Microbe 2017 Keynote Speaker Brings DNA Sequencing to Space
ASM member Kate Rubins, PhD, first individual to sequence DNA in space, shed light on her experience as a NASA astronaut in a keynote conversation at the ASM Microbe 2017 meeting in New Orleans, Louisiana.
Exploring the Link Between Steatosis Progression and HIV & HCV Infection
Not much is known about how HIV mono-infection contributes to the development of hepatic steatosis, due to how difficult diagnosis of this condition used to be. Now, with the developement of noninvasive tools, it is easier to diagnose steatosis.
Ebola Outbreak Seemingly Contained as Experimental Vaccine Approved for Use
As the Ebola outbreak in the Democratic Republic of Congo holds steady at 2 confirmed and 3 probable cases, the Ministry of Health has approved the administration of an experimental vaccine against the virus.
Big advances in treatment can